SABIC Said to be Seeking Acquisitions

Saudi Arabian chemical giant SABIC is seeking acquisitions to strengthen its fertilizer business and could announce a deal in the chemicals and polymers sectors by the end of the third quarter, its acting chief executive, Yousef Abdullah Al-Benyan, told the news agency Reuters. Al-Benyan said the fertilizer purchases would be outside Saudi Arabia would focus on ammonia, urea and specialty urea products.

He said SABIC is also evaluating whether to sell some of its assets in its polymers and specialty business, with a decision expected by the end of the year. Any divestments would most likely take place in Asia and the US.

In October 2015, Al-Benyan announced a corporate reorganization that he said would focus the company’s resources more intensively on the needs of each business line, following a trend embraced by Western chemical conglomerates in the past.

In particular, he said SABIC has realized that the different technology priorities of commodity and specialty businesses are different. Without commenting on specific plans, the acting CEO said the shift in priorities would require technology acquisitions and partnerships or joint ventures,

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.